{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T09:07:50Z","timestamp":1779959270617,"version":"3.53.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:00:00Z","timestamp":1778716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"crossref","award":["(N41A661109)"],"award-info":[{"award-number":["(N41A661109)"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"crossref"}]},{"name":"a temporary Research Assistantship from the Faculty of Medical Technology, Mahidol University"},{"name":"the National Research Council of Thailand (NRCT), and Mahidol University","award":["(N42A660378)"],"award-info":[{"award-number":["(N42A660378)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-026-03829-3","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:58:03Z","timestamp":1778763483000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aberrant sphingosine-1-phosphate receptor 1 expression on activated naive B cells associated with disease activity and lupus nephritis in systemic lupus erythematosus"],"prefix":"10.1186","volume":"28","author":[{"given":"Pachara","family":"Tianpothong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyawan","family":"Kochayoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanitta","family":"Suangtamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasicha","family":"Suksapan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pongsakorn","family":"Thawornpan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaniya","family":"Leepiyasakulchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pintip","family":"Ngamjanyaporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prapaporn","family":"Pisitkun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patchanee","family":"Chootong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,14]]},"reference":[{"key":"3829_CR1","doi-asserted-by":"publisher","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","volume":"2","author":"A Kaul","year":"2016","unstructured":"Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, van Vollenhoven R, et al. Systemic lupus erythematosus. Nat Rev Dis Primers. 2016;2:16039.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"3829_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41392-025-02168-0","volume":"10","author":"X Dai","year":"2025","unstructured":"Dai X, Fan Y, Zhao X. Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics. Signal Transduct Target Ther. 2025;10(1):102.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3829_CR3","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/imr.12815","volume":"292","author":"JA Hamilton","year":"2019","unstructured":"Hamilton JA, Hsu HC, Mountz JD. Autoreactive B cells in SLE, villains or innocent bystanders? Immunol Rev. 2019;292(1):120\u201338.","journal-title":"Immunol Rev"},{"key":"3829_CR4","doi-asserted-by":"publisher","first-page":"1267091","DOI":"10.3389\/fimmu.2023.1267091","volume":"14","author":"Y Xiang","year":"2023","unstructured":"Xiang Y, Zhang M, Jiang D, Su Q, Shi J. The role of inflammation in autoimmune disease: a therapeutic target. Front Immunol. 2023;14:1267091.","journal-title":"Front Immunol"},{"key":"3829_CR5","doi-asserted-by":"publisher","first-page":"9518137","DOI":"10.1155\/2020\/9518137","volume":"2020","author":"W Jin","year":"2020","unstructured":"Jin W, Luo Z, Yang H, Peripheral B. Cell Subsets in Autoimmune Diseases: Clinical Implications and Effects of B Cell-Targeted Therapies. J Immunol Res. 2020;2020:9518137.","journal-title":"J Immunol Res"},{"issue":"1","key":"3829_CR6","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13075-021-02557-0","volume":"23","author":"K Wangriatisak","year":"2021","unstructured":"Wangriatisak K, Thanadetsuntorn C, Krittayapoositpot T, Leepiyasakulchai C, Suangtamai T, Ngamjanyaporn P, et al. The expansion of activated naive DNA autoreactive B cells and its association with disease activity in systemic lupus erythematosus patients. Arthritis Res Ther. 2021;23(1):179.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"3829_CR7","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","volume":"49","author":"SA Jenks","year":"2018","unstructured":"Jenks SA, Cashman KS, Zumaquero E, Marigorta UM, Patel AV, Wang X, et al. Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus. Immunity. 2018;49(4):725\u2013e396.","journal-title":"Immunity"},{"key":"3829_CR8","doi-asserted-by":"crossref","unstructured":"Wangriatisak K, Kochayoo P, Thawornpan P, Leepiyasakulchai C, Suangtamai T, Ngamjanyaporn P, et al. CD4(+) T-cell cooperation promoted pathogenic function of activated na\u00efve B cells of patients with SLE. Lupus Sci Med. 2022;9(1):e000739.","DOI":"10.1136\/lupus-2022-000739"},{"issue":"6","key":"3829_CR9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41584-022-00784-6","volume":"18","author":"N Burg","year":"2022","unstructured":"Burg N, Salmon JE, Hla T. Sphingosine 1-phosphate receptor-targeted therapeutics in rheumatic diseases. Nat Rev Rheumatol. 2022;18(6):335\u201351.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"3829_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s40265-020-01431-8","volume":"81","author":"J Chun","year":"2021","unstructured":"Chun J, Giovannoni G, Hunter SF. Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects. Drugs. 2021;81(2):207\u201331.","journal-title":"Drugs"},{"issue":"5","key":"3829_CR11","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1084\/jem.20092210","volume":"207","author":"ML Allende","year":"2010","unstructured":"Allende ML, Tuymetova G, Lee BG, Bonifacino E, Wu YP, Proia RL. S1P1 receptor directs the release of immature B cells from bone marrow into blood. J Exp Med. 2010;207(5):1113\u201324.","journal-title":"J Exp Med"},{"issue":"12","key":"3829_CR12","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.it.2015.10.005","volume":"36","author":"A Baeyens","year":"2015","unstructured":"Baeyens A, Fang V, Chen C, Schwab SR. Exit Strategies: S1P Signaling and T Cell Migration. Trends Immunol. 2015;36(12):778\u201387.","journal-title":"Trends Immunol"},{"key":"3829_CR13","doi-asserted-by":"crossref","unstructured":"Strasser DS, Froidevaux S, Sippel V, Gerossier E, Grieder U, Pierlot GM, et al. Preclinical to clinical translation of cenerimod, a novel S1P(1) receptor modulator, in systemic lupus erythematosus. RMD Open. 2020;6(2):e001261.","DOI":"10.1136\/rmdopen-2020-001261"},{"key":"3829_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.molimm.2023.06.006","volume":"160","author":"J Tian","year":"2023","unstructured":"Tian J, Chang S, Wang J, Chen J, Xu H, Huang T, et al. S1P\/S1PR1 axis promotes macrophage M1 polarization through NLRP3 inflammasome activation in Lupus nephritis. Mol Immunol. 2023;160:55\u201366.","journal-title":"Mol Immunol"},{"issue":"10","key":"3829_CR15","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/ki.2008.396","volume":"74","author":"SE Wenderfer","year":"2008","unstructured":"Wenderfer SE, Stepkowski SM, Braun MC. Increased survival and reduced renal injury in MRL\/lpr mice treated with a novel sphingosine-1-phosphate receptor agonist. Kidney Int. 2008;74(10):1319\u201326.","journal-title":"Kidney Int"},{"key":"3829_CR16","doi-asserted-by":"publisher","first-page":"5821589","DOI":"10.1155\/2019\/5821589","volume":"2019","author":"K Sugahara","year":"2019","unstructured":"Sugahara K, Maeda Y, Shimano K, Murase M, Mochiduki S, Takemoto K, et al. Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models. J Immunol Res. 2019;2019:5821589.","journal-title":"J Immunol Res"},{"key":"3829_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.bbi.2018.03.009","volume":"70","author":"D Shi","year":"2018","unstructured":"Shi D, Tian T, Yao S, Cao K, Zhu X, Zhang M, et al. FTY720 attenuates behavioral deficits in a murine model of systemic lupus erythematosus. Brain Behav Immun. 2018;70:293\u2013304.","journal-title":"Brain Behav Immun"},{"key":"3829_CR18","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.3389\/fimmu.2019.02458","volume":"10","author":"I Sanz","year":"2019","unstructured":"Sanz I, Wei C, Jenks SA, Cashman KS, Tipton C, Woodruff MC, et al. Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations. Front Immunol. 2019;10:2458.","journal-title":"Front Immunol"},{"key":"3829_CR19","doi-asserted-by":"publisher","first-page":"616141","DOI":"10.3389\/fimmu.2020.616141","volume":"11","author":"S Hiramatsu-Asano","year":"2020","unstructured":"Hiramatsu-Asano S, Sunahori-Watanabe K, Zeggar S, Katsuyama E, Mukai T, Morita Y, et al. Deletion of Mir223 Exacerbates Lupus Nephritis by Targeting S1pr1 in Fas(lpr\/lpr) Mice. Front Immunol. 2020;11:616141.","journal-title":"Front Immunol"},{"issue":"12","key":"3829_CR20","doi-asserted-by":"publisher","first-page":"103934","DOI":"10.1016\/j.autrev.2025.103934","volume":"24","author":"D Nikolakis","year":"2025","unstructured":"Nikolakis D, Teichert C, Grootjans J, van de Sande MGH, D\u2019Haens GR. The effect of Sphingosine-1-phosphate receptor modulator treatment on leukocyte subsets across different clinical indications: A systematic review. Autoimmun Rev. 2025;24(12):103934.","journal-title":"Autoimmun Rev"},{"key":"3829_CR21","doi-asserted-by":"crossref","unstructured":"Schlicher L, Kulig P, von M\u00fcnchow A, Murphy MJ, Keller MP. In Vitro Characterization of Sphingosine 1-Phosphate Receptor 1 (S1P(1)) Expression and Mediated Migration of Primary Human T and B Cells in the Context of Cenerimod, a Novel, Selective S1P(1) Receptor Modulator. Int J Mol Sci. 2022;23(3):1191.","DOI":"10.3390\/ijms23031191"},{"issue":"7083","key":"3829_CR22","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nature04606","volume":"440","author":"LR Shiow","year":"2006","unstructured":"Shiow LR, Rosen DB, Brdickov\u00e1 N, Xu Y, An J, Lanier LL, et al. CD69 acts downstream of interferon-alpha\/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature. 2006;440(7083):540\u20134.","journal-title":"Nature"},{"issue":"8","key":"3829_CR23","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.4049\/jimmunol.180.8.5335","volume":"180","author":"M Gohda","year":"2008","unstructured":"Gohda M, Kunisawa J, Miura F, Kagiyama Y, Kurashima Y, Higuchi M, et al. Sphingosine 1-phosphate regulates the egress of IgA plasmablasts from Peyer\u2019s patches for intestinal IgA responses. J Immunol. 2008;180(8):5335\u201343.","journal-title":"J Immunol"},{"issue":"9","key":"3829_CR24","doi-asserted-by":"publisher","first-page":"e44362","DOI":"10.1371\/journal.pone.0044362","volume":"7","author":"PL Lugar","year":"2012","unstructured":"Lugar PL, Love C, Grammer AC, Dave SS, Lipsky PE. Molecular characterization of circulating plasma cells in patients with active systemic lupus erythematosus. PLoS ONE. 2012;7(9):e44362.","journal-title":"PLoS ONE"},{"key":"3829_CR25","doi-asserted-by":"crossref","unstructured":"Sikora JP, Karawani J, Sobczak J. Neutrophils and the Systemic Inflammatory Response Syndrome (SIRS). Int J Mol Sci. 2023;24(17):13469.","DOI":"10.3390\/ijms241713469"},{"key":"3829_CR26","first-page":"95","volume":"7","author":"D Kaushik","year":"2025","unstructured":"Kaushik D, Xu B, Kumar M. Biomarkers in immunology: Their impact on immune function and response. Adv Biomark Sci Technol. 2025;7:95\u2013110.","journal-title":"Adv Biomark Sci Technol"},{"issue":"9","key":"3829_CR27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/ncprheum0572","volume":"3","author":"E Dayer","year":"2007","unstructured":"Dayer E, Dayer JM, Roux-Lombard P. Primer: the practical use of biological markers of rheumatic and systemic inflammatory diseases. Nat Clin Pract Rheumatol. 2007;3(9):512\u201320.","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"6","key":"3829_CR28","first-page":"317","volume":"115","author":"C Bray","year":"2016","unstructured":"Bray C, Bell LN, Liang H, Haykal R, Kaiksow F, Mazza JJ, et al. Erythrocyte Sedimentation Rate and C-reactive Protein Measurements and Their Relevance in Clinical Medicine. WMJ. 2016;115(6):317\u201321.","journal-title":"WMJ"},{"issue":"1","key":"3829_CR29","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/mi.2016.35","volume":"10","author":"T Karuppuchamy","year":"2017","unstructured":"Karuppuchamy T, Behrens EH, Gonz\u00e1lez-Cabrera P, Sarkisyan G, Gima L, Boyer JD, et al. Sphingosine-1-phosphate receptor-1 (S1P(1)) is expressed by lymphocytes, dendritic cells, and endothelium and modulated during inflammatory bowel disease. Mucosal Immunol. 2017;10(1):162\u201371.","journal-title":"Mucosal Immunol"},{"key":"3829_CR30","doi-asserted-by":"crossref","unstructured":"Abarca-Zabal\u00eda J, Garc\u00eda MI, Lozano Ros A, Mar\u00edn-Jim\u00e9nez I, Mart\u00ednez-Gin\u00e9s ML, L\u00f3pez-Cauce B, et al. Differential Expression of SMAD Genes and S1PR1 on Circulating CD4\u2009+\u2009T Cells in Multiple Sclerosis and Crohn\u2019s Disease. Int J Mol Sci. 2020;21(2):676.","DOI":"10.3390\/ijms21020676"},{"issue":"2","key":"3829_CR31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1681\/ASN.2010050515","volume":"22","author":"M Espeli","year":"2011","unstructured":"Espeli M, B\u00f6kers S, Giannico G, Dickinson HA, Bardsley V, Fogo AB, et al. Local renal autoantibody production in lupus nephritis. J Am Soc Nephrol. 2011;22(2):296\u2013305.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"3829_CR32","doi-asserted-by":"publisher","first-page":"e13427","DOI":"10.1111\/sji.13427","volume":"101","author":"K Wangriatisak","year":"2025","unstructured":"Wangriatisak K, de Vries C, Sharma RK, Huang W, Gr\u00f6nwall C, Pisitkun P, et al. Association between peripheral activated naive and double negative 2 B-cell subsets and clinical parameters in lupus nephritis patients. Scand J Immunol. 2025;101(1):e13427.","journal-title":"Scand J Immunol"},{"issue":"1","key":"3829_CR33","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1038\/s41467-018-03750-7","volume":"9","author":"S Wang","year":"2018","unstructured":"Wang S, Wang J, Kumar V, Karnell JL, Naiman B, Gross PS, et al. IL-21 drives expansion and plasma cell differentiation of autoreactive CD11c(hi)T-bet(+) B cells in SLE. Nat Commun. 2018;9(1):1758.","journal-title":"Nat Commun"},{"key":"3829_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.molimm.2023.02.009","volume":"156","author":"G Wang","year":"2023","unstructured":"Wang G, Sun Y, Jiang Y, Li S, Liu Y, Yuan Y, et al. CXCR3 deficiency decreases autoantibody production by inhibiting aberrant activated T follicular helper cells and B cells in lupus mice. Mol Immunol. 2023;156:39\u201347.","journal-title":"Mol Immunol"},{"key":"3829_CR35","doi-asserted-by":"crossref","unstructured":"Chen H, Qin Y, Chou M, Cyster JG, Li X. Transmembrane protein CD69 acts as an S1PR1 agonist. Elife. 2023;12:e88204.","DOI":"10.7554\/eLife.88204"},{"issue":"8","key":"3829_CR36","doi-asserted-by":"publisher","first-page":"110455","DOI":"10.1016\/j.jbc.2025.110455","volume":"301","author":"MV Levesque","year":"2025","unstructured":"Levesque MV, Cartier A, Lin YC, Sah RK, Zhang H, Chaube B, et al. Inflamed endothelial cells express S1PR1 inhibitor CD69 to induce vascular leak. J Biol Chem. 2025;301(8):110455.","journal-title":"J Biol Chem"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-026-03829-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03829-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03829-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T08:50:30Z","timestamp":1779958230000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-026-03829-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,14]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3829"],"URL":"https:\/\/doi.org\/10.1186\/s13075-026-03829-3","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,14]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of the Faculty of Medicine Ramathibodi Hospital, Mahidol University (approval number is MURA 2015\/731). Each participant gave written informed consent before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}